SAT-238 Predictors Of Vaginal/Uterine Bleeding With Oral TX-001HR (Estradiol and Progesterone) Capsules Taken For Menopausal Vasomotor Symptoms

Vaginal bleeding associated with hormone therapy (HT) is the most common reason for treatment discontinuation. Cumulative amenorrhea rates (no bleeding or spotting for 13 cycles) ranging from 23% to 49% with current HT options(1-3) are relatively lower than the 56% to 73% observed in the REPLENISH t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Endocr Soc
Hlavní autoři: Constantine, Ginger, Goldstein, Steven, Pickar, James, Graham, Shelli, Bernick, Brian, Mirkin, Sebastian
Médium: Artigo
Jazyk:Inglês
Vydáno: Endocrine Society 2019
Témata:
Reproductive Endocrinology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6551826/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-238
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky